摘要:
A method and system for delivering announcement broadcasts. The method includes receiving an announcement broadcast from a broadcast system of a transportation station. The method also includes interpreting the received announcement broadcast using natural language processing to extract transportation information. The method also includes the received announcement broadcast and the extracted transportation information in a data storage location. The method also includes translating the stored announcement broadcast into a text message. The method also includes transmitting the text message to at least one mobile device of at least one user registered with the announcement broadcast delivery method, based on the transportation information and the user information stored in the data storage location.
摘要:
A duct assembly including a first duct and a second duct that are connected by a receptacle and a fitting that are moved in a transverse direction to assemble the first duct to the second duct. The receptacle defines a slot that includes an inner wall and an outer wall. The inner and outer wall define a fitting insertion opening on one lateral side and a fitting seat on the opposite lateral side. A seal is provided on a face wall of the fitting. Triangular side walls extend between the inner and outer walls. A locking tab on a triangular side wall is received within a tab receiver on the outer wall of the fitting.
摘要:
The invention relates to a biocompatible, non-biodegradable, and non-toxic polymer of formula (I), comprising of three monomeric units, selected from 1-Vinylpyrrolidone (VP), N-Isopropylacrylamide (NIPAM), and ester of Maleic anhydride and Polyethylene glycol (MPEG), cross-linked with a bi-functional vinyl derivative, of high purity and substantially free of respective toxic monomeric contaminants, and a process for preparation thereof. The invention further relates to nanoparticulate pharmaceutical compositions of poorly water-soluble drugs or compounds comprising the polymer of the invention, which are safe, less-toxic and convenient for bedside administration to patients in need thereof. Furthermore, the invention relates to a highly selective method for preparation of nanoparticulate pharmaceutical compositions of poorly water-soluble drugs or compounds.
摘要:
A novel deionization filter for removing ions from a coolant in an electric fuel cell vehicle cooling system is disclosed. The deionization filter includes a filter housing having a coolant inlet port, through which the coolant enters the filter housing; and a coolant outlet port, through which the coolant exits the filter housing. An ion exchange bed having positively-charged and negatively-charged ion exchange resin beads is provided in the filter housing for removing negative and positive ions, respectively, from the coolant. At least one filter assembly is typically provided in the filter housing for filtering particles from the coolant.
摘要:
A method for providing a porous metal implant. A mixture of a biocompatible metal, a spacing agent, and a binder is provided. The mixture is formed into a shaped the spacing agent is removed to form a plurality of pores in the implant. A shaped porous metal implant is also provided.
摘要:
Disclosed herein is a double stranded siRNA molecule that inhibits production of a respiratory virus, wherein each strand of said siRNA molecule is about 15 to about 50 nucleotides, and wherein one strand of said siRNA molecule comprises a nucleic acid sequence identical to a conserved site, or a variant thereof, within the nucleic acid sequence of the respiratory virus, and uses thereof.
摘要:
A flush and fill process is used to ready a fuel cell cooling circuit for initial use. An external flushing system releasably connected to the cooling circuit circulates flushing coolant through the cooling circuit to remove contaminants from the wetted surfaces of the cooling circuit before the fuel cell is put into use. The flushing system includes a pump for circulating the flushing coolant through the cooling circuit, filters for removing contaminants from the coolant and a heater for elevating the temperature of the coolant. Following the flushing process to remove contaminants, the flushing system is disconnected from the cooling circuit and the cooling circuit is filled with fresh coolant.
摘要:
The invention relates to a biocompatible, non-biodegradable, and non-toxic polymer of formula (I), comprising of three monomeric units, selected from 1-Vinylpyrrolidone (VP), N-Isopropylacrylamide (NIPAM), and ester of Maleic anhydride and Polyethylene glycol (MPEG), cross-linked with a bi-functional vinyl derivative, of high purity and substantially free of respective toxic monomeric contaminants, and a process for preparation thereof. The invention further relates to nanoparticulate pharmaceutical compositions of poorly water-soluble drugs or compounds comprising the polymer of the invention, which are safe, less-toxic and convenient for bedside administration to patients in need thereof. Furthermore, the invention relates to a highly selective method for preparation of nanoparticulate pharmaceutical compositions of poorly water-soluble drugs or compounds.
摘要:
A method for providing a porous metal implant. A mixture of a biocompatible metal, a spacing agent, and a binder is provided. The mixture is formed into a shaped the spacing agent is removed to form a plurality of pores in the implant. A shaped porous metal implant is also provided.
摘要:
The present invention pertains to methods and pharmaceutical compositions for modulating an immune response. The method of the present invention involves administration of an effective amount of nucleic acid molecules encoding interleukin-12 (IL-12), interferon-gamma (IFN-γ), or a combination thereof, to a patient in need of such treatment. The pharmaceutical compositions of the invention contain nucleic acid molecules encoding IL-12 and/or IFN-γ and an operably-linked promoter sequence. In another aspect, the present invention concerns expression vectors containing a nucleotide sequence encoding IL-12 and IFN-γ, and an operably-linked promoter sequence. In another aspect, the present invention concerns cells genetically modified with a nucleotide sequence encoding IL-12 and IFN-γ.